Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy using tissue-specific replication competent HSV.

Shin-Ichi Miyatake1

  • 1Department of Neurosurgery, Osaka Medical College, Osaka, Japan. neu070@poh.osaka-med.ac.jp

Human Cell
|April 22, 2003
PubMed
Summary

This study introduces a novel gene therapy approach using engineered herpes simplex virus type 1 vectors for cell-specific targeting. These vectors, G92A and d12.CALP, demonstrate targeted replication in albumin- or calponin-expressing cells, showing promise for cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study.

Neuro-oncology·2026
Same author

Extended follow-up of recurrent glioblastoma patients treated with boron neutron capture therapy (BNCT): Long-term survival from a Phase II trial (JG002) using Cyclotron Neutron Source and Boronophenylalanine.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author

[Defining the Role of Radiotherapy in Meningioma Treatment].

No shinkei geka. Neurological surgery·2024
Same author

Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.

Scientific reports·2024
Same author

Expression and distribution of hypoxia-inducible factor-1α and vascular endothelial growth factor in comparison between radiation necrosis and tumor tissue in metastatic brain tumor: A case report.

Neuropathology : official journal of the Japanese Society of Neuropathology·2023
Same author

Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated <i>closo</i>-Dodecaborate on a Rat Brain Tumor Model.

Biology·2023

Area of Science:

  • Viral Gene Therapy
  • Molecular Virology
  • Oncology

Background:

  • Cell-specific targeting of gene therapy vectors is crucial for efficacy and safety.
  • Herpes simplex virus type 1 (HSV-1) vectors offer potential for gene delivery but require precise control over replication.
  • Developing vectors that replicate only in target cells can enhance therapeutic outcomes and minimize off-target effects.

Purpose of the Study:

  • To develop and validate novel HSV-1 vectors for tissue- or cell-specific gene therapy.
  • To demonstrate that regulated expression of an essential viral gene product can confine viral replication and cytotoxicity to specific cell types.
  • To evaluate the therapeutic potential of these targeted vectors in preclinical models of cancer and vascular disease.

Main Methods:

Related Experiment Videos

  • Construction of two HSV-1 vectors, G92A and d12.CALP, engineered for replication in albumin-expressing (liver, hepatocellular carcinoma) and calponin-expressing (smooth muscle) cells, respectively.
  • In vitro assessment of vector replication in various human cell lines, comparing targeted vectors with a non-specific HSV recombinant (hrR3).
  • In vivo evaluation of vector replication and therapeutic efficacy in tumor xenografts and animal models of vascular injury.

    • Main Results:

    • G92A demonstrated efficient and specific replication in albumin-expressing hepatoma cell lines in vitro and in vivo, while not replicating in non-albumin-expressing tumor cells.
    • G92A inhibited the growth of hepatoma tumors but not prostate tumors, indicating cell-specific therapeutic effects.
    • D12CALP showed cell-specific replication in calponin-expressing leiomyosarcoma.
    • The non-specific vector hrR3 inhibited restenosis in rat carotid arteries, but targeted vectors aim to improve safety by limiting proliferation to specific cell types.

    Conclusions:

    • Engineered HSV-1 vectors can achieve highly specific replication in target cells by regulating essential viral gene expression.
    • This cell-specific viral replication strategy holds significant potential for targeted cancer therapy and the development of animal models.
    • Further research on d12.CALP will explore applications in arteriosclerosis and post-transplantation complications.